Literature DB >> 20594242

Ecabet sodium: a potential new agent in the management of distal colitis.

Ian C Lawrance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594242     DOI: 10.1111/j.1440-1746.2010.06339.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  2 in total

1.  Safety and tolerability of bismuthyl ecabet suspension, a novel anti-ulcer agent, following single and multiple oral dose administration in healthy Chinese subjects.

Authors:  Yongqing Wang; Nana Tang; Ling Meng; Peipei Zhang; Kun Xu; Ningling Jiang; Haibo Zhang; Ning Ou; Deqin Wu; Anjiu Chen; Xiyong Zhang; Ruihua Shi
Journal:  Clin Drug Investig       Date:  2012-04-01       Impact factor: 2.859

Review 2.  What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?

Authors:  Ian C Lawrance
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.